CPAX and POC troponin testing device for patients with heart disease and cognitive impairment – NHS Innovation Service (ISSN 2753-8176 (online))
CPAX and POC troponin testing device for patients with heart disease and cognitive impairment – NHS Innovation Service (ISSN 2753-8176 (online)) 1. Ana Pedro 1.Gwyntwr1386 Pharmacy, Regus Chester Business Park, Heronsway, Chester, CH49QR, UK. info@gwyntwr1386.com We concluded that most MCA users are elderly patients. Also, most of the patients suffer of combined cardiovascular disease. We intend to do an assessment of feasibility about providing a new online clinical delivery and treatment monitoring service for the NHS based on the CpaX medication management program from Jones Healthcare group in Canada coupled with a POC troponin test in helping patients with cognitive impairment and/or heart disease taking their medication properly. Is your innovation relevant to any of the following areas? Independence and prevention Digitalising the system Improving system flow Operational excellence Patient activation and self-care Patient safety and quality improvement Workf...